L1 Capital Global Opportunities Master Fund, Ltd. - 31 Dec 2024 SCHEDULE 13G/A Report for Sunshine Biopharma Inc. Common Stock, $0.001 par value (SBFM)

Filing manager
L1 Capital Global Opportunities Master Fund, Ltd.
Reporting owner
L1 Capital Global Opportunities Master Fund, Ltd.
Security
Sunshine Biopharma Inc. Common Stock, $0.001 par value
Beneficially owned shares
142,244 shares
Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13G/A

Passive or exempt beneficial ownership filing.

Ownership

5%

Beneficial ownership of this reported class.

Shares

142,244 shares

Shares beneficially owned as disclosed.

Event date

31 Dec 2024

Date tied to the ownership event or amendment.

Accepted by SEC

14 Feb 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership
5%
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
SBFM
Shares outstanding
2,850,581 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13G/A
Accepted by SEC
14 Feb 2025, 16:43:20 UTC
Event date
31 Dec 2024
Next SEC filing
22 May 2026
Source filing
View source filing

Key filing fact

L1 Capital Global Opportunities Master Fund, Ltd. disclosed 5% ownership in Sunshine Biopharma Inc. Common Stock, $0.001 par value (SBFM) on 31 Dec 2024.

Key facts

  • L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G/A for Sunshine Biopharma Inc. Common Stock, $0.001 par value (SBFM).
  • Disclosed ownership: 5%.
  • Date of event: 31 Dec 2024.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:43.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (1)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
L1 Capital Global Opportunities Master Fund, Ltd. 5% 142,244 142,244 0 /s/ David Feldman David Feldman, Director
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .